CaSfA - Cancer Support for All
News from CaSfA's Director

New Finding in Triple Negative Breast Cancer

Researchers in the UK have found an overactive gene, BCL11A, in 8 out of 10 patients with triple-negative breast cancer.  This type of cancer is especially aggressive. Without estrogen, progesterone and HER2 receptors targeted therapy using tamoxifen, aromatase inhibitors, and Herceptin do not work.  Finding this gene is the first step in developing targeted therapy for this type of breast cancer.  ( )

0 Comments to New Finding in Triple Negative Breast Cancer:

Comments RSS

Add a Comment

Your Name:
Email Address: (Required)
Make your text bigger, bold, italic and more with HTML tags. We'll show you how.
Post Comment
Website Builder provided by  Vistaprint